ProQR Therapeutics Market Sentiment

ProQR Therapeutics NV

PRQRNASDAQ

Trade with Public

$1.63

-0.03-1.81%

Ult. Agg.: Oct 1, 7:35 PM

$1.64

-0.02-1.2%

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

ProQR Therapeutics Market Sentiment - Benzinga

ProQR Therapeutics Market Sentiment

Market sentiment signals for ProQR Therapeutics (PRQR): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.2% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

—

Avg Consensus PT

+387.8%

Highest Price Target

$14

+753.7%

Raymond James

Lowest Price Target

+22.0%

Citigroup

Short Interest

2.2%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 1, 2026	Chardan Capital	Keay Nakae—	+82.9%	$3 → $3	Maintained	Buy
Oct 1, 2026	HC Wainwright & Co.	Ananda Ghosh—	+387.8%	$12 → $8	Maintained	Buy
Aug 20, 2026	B of A Securities	Alec Stranahan—	+387.8%	$8	Initiate	Buy
Jun 29, 2026	Evercore ISI Group	Gavin Clark-Gartner—	+265.9%	$5 → $6	Maintained	Outperform
Jun 26, 2026	Jones Trading	Catherine Novack—	+509.8%	$11 → $10	Maintained	Buy
Jun 26, 2026	Chardan Capital	Keay Nakae—	+82.9%	$4 → $3	Maintained	Buy
Apr 9, 2026	Chardan Capital	Keay Nakae—	+143.9%	$4 → $4	Maintained	Buy
Nov 4, 2025	Chardan Capital	Keay Nakae—	+143.9%	$4 → $4	Maintained	Buy
Aug 8, 2025	Chardan Capital	Keay Nakae—	+143.9%	$4 → $4	Maintained	Buy
Jun 27, 2025	Cantor Fitzgerald	Timur Ivannikov—	+387.8%	$8 → $8	Maintained	Overweight
Jun 27, 2025	JMP Securities	Jonathan Wolleben—	+387.8%	$8 → $8	Maintained	Market Outperform
May 13, 2025	Oppenheimer	Andreas Argyrides—	+448.8%	$15 → $9	Maintained	Outperform
Apr 29, 2025	Evercore ISI Group	Gavin Clark-Gartner—	+204.9%	$5	Initiate	Outperform
Mar 14, 2025	Chardan Capital	Keay Nakae—	+143.9%	$4 → $4	Maintained	Buy
Mar 14, 2025	HC Wainwright & Co.	Andrew Fein—	+631.7%	$10 → $12	Maintained	Buy
Feb 12, 2025	Jones Trading	Catherine Novack—	+570.7%	$11	Initiate	Buy
Dec 12, 2024	JMP Securities	Jonathan Wolleben—	+387.8%	$8 → $8	Maintained	Market Outperform
Dec 12, 2024	Chardan Capital	Keay Nakae—	+143.9%	$4 → $4	Maintained	Buy
Dec 12, 2024	HC Wainwright & Co.	Andrew Fein—	+509.8%	$10 → $10	Maintained	Buy
Nov 8, 2024	HC Wainwright & Co.	Andrew Fein—	+509.8%	$5 → $10	Maintained	Buy
Oct 29, 2024	Raymond James	Steven Seedhouse—	+753.7%	$6 → $14	Upgrade	Outperform→Strong Buy
May 10, 2024	HC Wainwright & Co.	Andrew Fein—	+204.9%	$5 → $5	Maintained	Buy
May 10, 2024	Chardan Capital	Keay Nakae—	+52.4%	$3 → $3	Maintained	Buy
Apr 18, 2024	Citigroup	Yigal Nochomovitz—	+22.0%	$2 → $2	Maintained	Neutral
Mar 14, 2024	HC Wainwright & Co.	Andrew Fein—	+204.9%	$5 → $5	Maintained	Buy